Learning pointsPoint-of-care ultrasound, when used by primary care physicians with training, allows detection of important functional and structural cardiac abnormalities.A pocket ultrasound can be used as a physical examination complement, supporting the differential diagnosis of dyspnoea and efficient decision-making process.

Introduction
============

Echocardiography has been traditionally performed in echo labs, but in the latest years, it has been expanded to other environments, such as hospital urgent care. The advantages of the use of echocardiography by primary care physicians (PCPs) is unexplored, although PCPs are in the front line evaluation of most of the patients.[@ytz179-B1]

We present a case report of a patient with heart failure (HF) where echocardiography was instrumental for comprehensive patient evaluation and clinical decision, illustrating a significant improvement in the efficiency of primary healthcare.

Timeline
========

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------
  4 years prior to presentation                                                                                                                                    No prior history of heart failure at presentation
  At presentation                                                                                                                                                  85-year-old woman requests family doctor home consultation due to progressive dyspnoea
  Dyspnoea \[New York Heart Association (NYHA) Class III--IV\], orthopnoea, pulmonary rales, and bilateral ankle oedema                                            
  Point-of-care ultrasound with pocket echo by family doctor: severely compromised left ventricular systolic function, severe dilation of the inferior vena cava   
  Treatment: spironolactone 25 mg daily; increased furosemide 40 mg 3 times daily                                                                                  
  1 month later                                                                                                                                                    Dyspnoea (NYHA Class II--III)
  Conventional echocardiography: reduced ejection fraction (30%)                                                                                                   
  Replaces ramipril to sacubitril/valsartan                                                                                                                        
  2 months later                                                                                                                                                   Heart failure symptoms relief
  Titrate sacubitril/valsartan dose                                                                                                                                
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------

Case presentation
=================

We present a case of an 85-year-old woman with medical history of arterial hypertension, obesity, and atrial fibrillation, living independently in her own house. Her regular medication included ramipril 10 mg od acenocoumarol, bisoprolol 5 mg od, pantoprazole 20 mg od and furosemide 40 mg od. We speculate patient had been advised by a different healthcare provider on this high diuretic dose due to swollen legs or other signs of congestion.

The patient requests her family doctor for a home consultation by aggravated dyspnoea. She was found with fatigue, tiredness, orthopnoea and dyspnoeic at rest. Physical examination revealed a blood pressure of 100/60 mmHg, heart rate of 98 b.p.m., elevated jugular venous pressure, third heart sound, pulmonary rales in the lower third of both lungs, and bilateral ankle oedema. Her medical records showed a glomerular filtration rate of 55 mL/min and an echocardiogram performed 4 years prior showed normal biventricular function without signs of pulmonary artery hypertension and mild mitral regurgitation. In regard to the severity of the symptoms, the patient was suggested to pursue further evaluation and treatment at the local hospital, but she refused to leave her house. On-site, the PCP with echocardiography training (certified online course and a practical training in an echocardiography lab for 6 months) performed a point-of-care ultrasound (POCUS) Lumify^®^. The study showed: severely compromised left ventricular (LV) systolic function (*[Figure 1](#ytz179-F1){ref-type="fig"}*, [Supplementary material online](#sup1){ref-type="supplementary-material"}, *Video S4*), moderate mitral (*[Figure 2](#ytz179-F2){ref-type="fig"}*), and tricuspid regurgitation (*[Figure 3](#ytz179-F3){ref-type="fig"}*), severe dilation of the inferior vena cava (*[Figure 4](#ytz179-F4){ref-type="fig"}*), severely dilated left atrium (52 mm in long-axis view), dilated right atrium (minor axis of 49 mm in four-chamber view), normal LV size (47 mm in diastole parasternal long-axis view), normal right ventricular (RV) size (basal and mid diameter of 39 and 29 mm), and normal RV function (tricuspid annular plane systolic excursion of 19 mm). Ultrasound B-lines were not assessed at this time. The study was shared live using a real-time programme (REACTS) with a cardiologist who confirms the findings. As a result, the diagnosis of HF with decreased ejection fraction (EF) was performed supporting the therapeutic decision: furosemide 40 mg was increased to three times daily and spironolactone 25 mg was introduced once daily. The patient had weekly visits from the community nurse and one month later, a conventional echocardiogram confirmed the POCUS findings, quantifying left ventricular ejection fraction in 30% and pulmonary artery pressure in 44 mmHg. At this time, ramipril was replaced by sacubitril/valsartan 24 mg/26 mg td. The patient refused additional studies or hospital referral, which limited our ability to study the cause of HF. At two months, follow-up the patient was tolerating treatment and presented in Class II of New York Heart Association and the sacubitril/valsartan was titrated accordingly.

![A four-chamber view with end-diastolic and systolic volumes. Reduced ejection fraction of 38% ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *Video S4*).](ytz179f1){#ytz179-F1}

![A four-chamber view with moderate mitral regurgitation.](ytz179f2){#ytz179-F2}

![Parasternal short-axis view with moderate tricuspid regurgitation.](ytz179f3){#ytz179-F3}

![In subcostal view, enlarged inferior vena cava at expiration (*A*) and inspiration (*B*) shows respiratory variation \>50%.](ytz179f4){#ytz179-F4}

Discussion
==========

Heart failure prevalence has been increasing in the last decades, alongside with population aging, especially in developed countries.[@ytz179-B1] However, the diagnosis of HF, as a clinical syndrome can be challenging, particularly in elderly patients, being the information provided by ultrasound fundamental for diagnosis and therapeutic management.[@ytz179-B2]

This case represents an 85-year-old female patient with dyspnoea, without previous HF diagnosis, refusing to leave her home, to whom the PCP successfully used portable ultrasound as a physical examination complement. The comprehensive evaluation allowed a confident diagnosis of HF at patient's home and a timely and targeted therapy avoiding hospital admission, showing that the use of ultrasound by a trained primary care physician increases the efficiency of medical care for the diagnosis and treatment of HF. The available studies are very limited and no cost-effectiveness studies have been done to prove the use POCUS as a toll by PCPs, however, this technique has been proven to be a useful, reliable and fast tool in emergency department and as a bedside physical examination complement.[@ytz179-B3]

In addition to HF recognition, HF should be monitored and medication optimized periodically. PCPs can play a critical role in this regard, in close collaboration with cardiologists, evaluating elderly patients who require home visits. In fact, a randomized clinical trial in patients with HF with optimal medical therapy showed no differences in death and hospital admissions between patients followed by cardiologists with those followed by referral PCP.[@ytz179-B7]

Conclusions
===========

In summary, the crescent ageing population presents new demands to the healthcare system and chronic diseases such as HF are more commonly being diagnosed and treated by PCPs, who by using portable ultrasounds, as 'fifth pillar to bedside physical examination' will significant improve patient care.[@ytz179-B2]
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